Kawchak K. Cost containment of global monoclonal antibody drugs and cancer clinical trials via LLM focused reasoning. Zenodo. 2025; doi:10.5281/zenodo.14968404 This content is a preprint and has not been peer-reviewed.

Kawchak K. Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968289 This content is a report and has not been peer-reviewed. Full Study

Kawchak K. Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968162 This content is a preprint and has not been peer-reviewed. 

Kawchak K. Cancer vs. Conversational Artificial Intelligence. bioRxiv. 2024; doi:10.1101/2024.12.28.630597 This content is a preprint and has not been peer-reviewed.

Kawchak K. mAb Bioprocess Engineering In-Context Table Forecasts using Conversational AI Literature Insight Generations. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-jzbj0 This content is a preprint and has not been peer-reviewed. 

Kawchak K. Monoclonal Antibody Bioprocess Engineering Advancements Using Conversational Artificial Intelligence. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-3m7m1 This content is a preprint and has not been peer-reviewed. 

Kawchak K. Paclitaxel Biosynthesis AI Breakthrough. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-pqjd3 This content is a preprint and has not been peer-reviewed.

Kawchak K. High Dimensional and Complex Spectrometric Data Analysis of an Organic Compound using Large Multimodal Models and Chained Outputs. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-06gf1 This content is a preprint and has not been peer-reviewed. 

Kawchak K. LMM Spectrometric Determination of an Organic Compound. ChemRxiv. 2024; doi:10.26434/chemrxiv-2024-qtnkj This content is a preprint and has not been peer-reviewed.